SANOFI CONS HEALTHC IND L Asset Resilience Ratio
SANOFI CONS HEALTHC IND L asset resilience ratio. SANOFI CONS HEALTHC IND L (SANOFICONR) has an Asset Resilience Ratio of 0.07% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SANOFICONR days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of SANOFI CONS HEALTHC IND L (2024–2025)
Asset resilience ratio of SANOFI CONS HEALTHC IND L from 2024 to 2025. This chart shows how SANOFI CONS HEALTHC IND L's Asset Resilience Ratio has changed over time. Read SANOFICONR liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down SANOFI CONS HEALTHC IND L's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SANOFICONR current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs4.00 Million | 0.07% |
| Total Liquid Assets | Rs4.00 Million | 0.07% |
Asset Resilience Insights
- Limited Liquidity: SANOFI CONS HEALTHC IND L maintains only 0.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SANOFI CONS HEALTHC IND L Industry Peers by Asset Resilience Ratio
Compare SANOFI CONS HEALTHC IND L's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 0.08% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.33% |
|
Novartis AG
MX:NVSN |
Drug Manufacturers - General | 0.08% |
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 0.00% |
|
Organon & Co
NYSE:OGN |
Drug Manufacturers - General | 4.46% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
Drug Manufacturers - General | 1.97% |
SANOFI CONS HEALTHC IND L Asset Resilience Ratio by Year (2024–2025)
SANOFI CONS HEALTHC IND L asset resilience ratio by year from 2024 to 2025. The table below shows the annual Asset Resilience Ratio data for SANOFI CONS HEALTHC IND L.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.07% | Rs4.00 Million ≈ $43.26K |
Rs5.47 Billion ≈ $59.16 Million |
-0.81pp |
| 2024-12-31 | 0.88% | Rs38.00 Million ≈ $410.96K |
Rs4.31 Billion ≈ $46.64 Million |
-- |
About SANOFI CONS HEALTHC IND L
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more